Opdualag 240-80 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DR26FCQ0W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,466
Award facts
- Contract value 100% obligated
- $41,465.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $41,465.56 to AmerisourceBergen Drug Corp for OPDUALAG 240-80 mg/20 ml vials on November 18, 2025, with completion expected by December 10, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, a comprehensive $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated substantial capability in federal medical procurement through its extensive portfolio of delivery orders with the Defense Logistics Agency's Medical Supply Chain. The company's federal contract awards reflect consistent competitively-awarded agreements covering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This delivery order for OPDUALAG supports the Defense Health Agency and broader military healthcare systems requiring reliable access to critical pharmaceutical commodities through DLA's structured procurement mechanisms.
Quick answers
Who was awarded contract SPE2DR26FCQ0W?
SPE2DR26FCQ0W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FCQ0W worth?
The government has obligated $41,466 on SPE2DR26FCQ0W.
Is contract SPE2DR26FCQ0W an order under another contract?
Yes. SPE2DR26FCQ0W is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCQ0W competed?
The extent of competition for SPE2DR26FCQ0W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award